Innopharmax: Innopharmax Inc 4172 Financial and Strategic SWOT Analysis Review Updated 15052017 Prices from USD $300
SummaryInnopharmax Inc. InnoPharmax a subsidiary of Synmosa Biopharma Corporation is a specialty pharmaceutical company that focuses on the development and commercialization of products for the treatment of specialty and oncology. The company offers antiin...
Read full article »
CEO
Innopharmax is a Private company. Innopharmax generates $31.4K in revenue per employee Innopharmax has 2 followers on Owler.